Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
CT

CTKB

Market Closed

Cytek Biosciences, Inc.

NASDAQHealthcareMedical - Devices
US
682 employees
CEO: Wenbin Jiang
Founded: 2021
$4.73
+$0.00(+NaN%)
Market Cap
610.84M
Beta
1.19
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Based on PERT weighted analysis (confidence: high), the fair value is $3.19, implying 32.2% downside from current levels. The stock appears significantly overvalued. Financial health scores indicate moderate fundamentals (2.2/5). Monte Carlo analysis shows high downside risk (100% of scenarios below current price). Overall, this suggests a elevated valuation risk at current prices.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore CTKB

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

CTKB in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →